Attenuated response to SARS-CoV-2 vaccine in patients with asymptomatic precursor stages of multiple myeloma and Waldenstrom macroglobulinemia

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Cancer cell 2022-01, Vol.40 (1), p.6-8
Hauptverfasser:	Konishi, Yoshinobu, Sklavenitis-Pistofidis, Romanos, Yue, Hong, Ferrari, Federico, Redd, Robert A., Lightbody, Elizabeth D., Russo, Massimiliano, Perry, Jacqueline, Horowitz, Erica, Justis, Anna V., Shayegh, Nader A., Savell, Alexandra, Prescott, Julia, Varmeh, Shohreh, Nowak, Radosław P., Hamilton, Mark, Auclair, Daniel, Marinac, Catherine R., Trippa, Lorenzo, Fischer, Eric S., Ghobrial, Irene M.
Format:	Artikel
Sprache:	eng
Schlagworte:	Ad26COVS1 - immunology Antibodies, Viral - biosynthesis Asymptomatic Diseases BNT162 Vaccine - immunology COVID-19 - epidemiology COVID-19 - prevention & control COVID-19 Vaccines Female Humans Immunocompromised Host Immunogenicity, Vaccine Immunoglobulin G - biosynthesis Immunologic Tests Letter Male Models, Immunological Multiple Myeloma - immunology Prospective Studies Risk SARS-CoV-2 - immunology Waldenstrom Macroglobulinemia - immunology
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!